About Technology Issues FAQ

Links

Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs

Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.